INVA Innoviva, Inc.

$22.50 -0.73%

Healthcare · Pharmaceutical Preparations

Innoviva, Inc. (INVA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.7 billion. Shares last traded at $22.50, 16.1% below their 52-week high. Over the past year the stock is up 4.9%. INVA trades at a price-to-earnings ratio of 6.12, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 65.9%, above the peer median of -0.1%. Revenue grew 14.7% year over year.

Market Cap

$1.7B

Shares Out

73.8M

EPS (TTM)

$3.07

P/E Ratio

7.33

P/S Ratio

4.04

P/B Ratio

1.24

Dividend / Share

—

Dividend Yield

—

52-Week High

$26.80

52-Week Low

$16.59

Volume

30,422

Avg Vol (3m)

37,270.048

Performance

+0.13%

+3.52%

+1.79%

+12.98%

YTD

+13.15%

+4.95%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.56

SMA (50)

$22.81

SMA (200)

$21.06

Price vs SMA50

-1.37%

Price vs SMA200

+6.83%

ATR (14)

$1.05

Financials

Revenue

$411M

Net Income

$271M

Gross Margin

74.8%

Operating Margin

39.8%

Net Margin

65.9%

Return on Equity

20.2%

Return on Assets

14.8%

Current Ratio

21.13

Debt / Equity

0.19

Revenue Growth (YoY)

+14.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$2.22	2026-05-06
FY 2025	$3.30	2026-02-25
Q3 2025	$1.35	2025-11-05
Q2 2025	$0.24	2025-08-06
Q1 2026	$-0.74	2026-05-06
FY 2025	$0.36	2026-02-25

Full earnings history →

Pharmaceutical Preparations peers

INVA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

6.12 / 16.82 med

-64% discount

P/S vs peers

4.04 / 3.54 med

+14% premium

Net margin vs peers

65.9% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.